Skip to main content
Clinical Trials/NCT02923427
NCT02923427CompletedNot Applicable

Comparison of I-gel and LMA Supreme Without Neuromuscular Blocker in Laparoscopic Gynecological Surgery

Dokuz Eylul University2 sites in 2 countries112 target enrollmentStarted: November 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
112
Locations
2
Primary Endpoint
Airway Seal Pressure Values

Study Overview

Brief Summary

To compare the effects of i-gel and Laryngeal mask airway Supreme (LMA-Supreme) on ventilation parameters and surgical view during Trendelenburg Position laparoscopic gynecological surgery in cases administered positive pressure ventilation without the use of neuromuscular agents.

Detailed Description

Prospective, randomized and double-blind study, aged from 18 to 65 years undergoing elective laparoscopic gynecological surgery.

The patients are randomly assigned to 2 groups:

  • Group 1: i-gel
  • Group 2: LMA- Supreme

Procedure:

The investigation protocol contains the following sections:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • American Society of Anesthesiologists classification group I-II
  • between 18-65 years
  • undergoing elective laparoscopic gynecological surgery

Exclusion Criteria

  • Those with any neck or upper respiratory tract pathology
  • Those at risk of gastric content regurgitation/aspiration (previous upper Gastrointestinal system surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcers, full stomach, pregnancy)
  • Those with low pulmonary compliance or high airway resistance (chronic pulmonary diseases)
  • Obese patients (BMI >35)
  • Those with throat pain, dysphagia and dysphonia
  • Those with possible or previous difficult airway
  • Those with operations planned for longer than 4 hours
  • Conversion to laparatomy
  • Neuromuscular blocking agent used

Outcomes

Primary Outcomes

Airway Seal Pressure Values

Time Frame: At baseline and at 15, 30 and 60 minutes

This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.

Secondary Outcomes

  • Mean Airway Pressure Values(At baseline and at 15, 30 and 60 minutes)
  • Sufficiency of Pneumoperitoneum(baseline)
  • Disphagia(postoperative first hour and 24th hour)
  • Visual Quality(during pneumoperitoneum)
  • Gastric Tube Insertion(following airway device insertion up to 5 minutes)
  • Postoperative Pharyngolaryngeal Morbidity(postoperative first hour and 24th hour)
  • Dysphonia With Yes/no.(postoperative first hour and 24th hour)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sule Ozbilgin

Dokuz Eylul University, MD, Anesthesiologists.

Dokuz Eylul University

Study Sites (2)

Loading locations...

Similar Trials

I-gel vs LMA Supreme in Laparoscopic... | Clinical Trial